At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 88 enrolled
Drug / intervention
Moringa oleifera leaf +1 moredrug
Likely dose
Moringa oleifera leaf 450 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Moringa Oleifera Capsule in Increasing Breast Milk Volume in Early Postpartum Patients: A Double Blind Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Moringa oleifera leaf and Placebo for Postpartum Women. Completed, enrolled 88 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effect of Moringa oleifera leaf capsule in increasing breast milk volume
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostpartum Women
CountriesThailand
Collaborators--
Timeline
Phase 4CompletedFinished
202120222023202420252026
First PostedJul 2020
Enrollment StartMar 2021
Primary CompletionMay 2022
Study CompletionJun 2022
TodayJul 2026
First PostedJul 27, 2020
Enrollment StartMar 15, 2021
Primary CompletionMay 31, 2022
Study CompletionJun 30, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.9 years ago
Interventions
Moringa oleifera leafdrug
450 mg capsule
Placebodrug
placebo capsule